Complete case analysis | 2011–2015 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Muscle-invasive (pT2+) | Non-muscle-invasive (pT1) | Unadjusted odds ratio (95% CI) | Adjusteda odds ratio (95% CI) | Unadjusted odds ratio (95% CI) | Adjusteda odds ratio (95% CI) | ||||
n | % | n | % | ||||||
Non-users (n = 7392) | 3854 | 52.1 | 3538 | 47.9 | Ref. | Ref. | Non-users (n = 3938) | Ref. | Ref. |
AD users (n = 860) | 437 | 50.8 | 423 | 49.2 | 0.95 (0.82–1.09) | 0.86 (0.74–0.99) | AD users (n = 490) | 0.96 (0.79–1.16) | 0.87 (0.71–1.05) |